January 9, 2013 at 9:03 PM On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world. But parasites are not […]Continue Reading ...
October 8, 2016 at 9:40 AM Mathematical modeling of the brain scans of patients with Alzheimer’s disease and others at risk for the devastating neurodegenerative disorder has identified specific patterns of brain atrophy that appear to be related to the loss of particular cognitive abilities. In their report that has been published online in the […]Continue Reading ...
October 6, 2016 at 3:03 AM Ben-Gurion University of the Negev (BGU) researchers are a step closer to understanding the genetic basis of autism, which they hope will lead to earlier diagnosis of what is rapidly becoming the most prevalent developmental disorder worldwide. In the study published in Behavior Genetics, the researchers examined the sequences […]Continue Reading ...
December 18, 2013 at 6:16 AM Demonstrates Takeda’s commitment to bring new, innovative treatments to patients Takeda Pharmaceuticals International GmbH (“Takeda”) today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened […]Continue Reading ...
July 31, 2012 at 10:45 PM InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2012. Total revenues for the second quarter of 2012 were $1.8 million, a decrease of $1.3 million from the same quarter of 2011. InSite Vision had cash, cash equivalents and short-term investments of $17.6 million […]Continue Reading ...
February 17, 2017 at 2:16 AM The University of Alabama at Birmingham will partner with Proton International to bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama. Proton therapy delivers a more precise dose of radiation to a tumor and can avoid damage to healthy surrounding tissue better than […]Continue Reading ...
February 8, 2017 at 3:26 PM Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research. “This is the first study to quantify the numbers of various immune cell types in breast […]Continue Reading ...
By Helen Albert, Senior medwireNews ReporterFebruary 26, 2013 at 5:15 PM Intense or “de qi” acupuncture produces significantly better results when added to prednisone treatment than low-intensity acupuncture for patients with Bell’s palsy, show findings from a randomized controlled trial. “The traditional Chinese theory of acupuncture emphasizes that the intensity of acupuncture must reach a […]Continue Reading ...
September 6, 2016 at 12:39 PM Researchers in Pennsylvania and Iowa have discovered that fungal communities found in chronic wounds can form mixed bacterial-fungal biofilms and can be associated with poor outcomes and longer healing times. Their report, the first deep characterization of the fungi found in diabetic foot ulcers, is published this week in […]Continue Reading ...
September 6, 2012 at 1:02 AM InSite Vision Incorporated (OTCBB: INSV) today introduced DuraSite 2®, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics. DuraSite 2 increases the tissue penetration for topically delivered ocular drugs with the aim of improved efficacy and dosing convenience. The company also announced […]Continue Reading ...
November 18, 2015 at 12:48 AM A study led by the University of Utah School of Medicine provides new insights into how the subtle changes within cells, caused by disruptions in a gene called Kirrel3, could underlie some types of intellectual disability and autism. A second paper to be published on the same day in […]Continue Reading ...
February 1, 2013 at 8:14 AM Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has launched clobetasol emulsion propionate foam, 0.05%, the generic equivalent of Olux® -E Foam, 0.05%. Perrigo will commence shipment of the product immediately. As Perrigo was the first generic filer against this product, it has 180 days of generic exclusivity. The launch date was […]Continue Reading ...
June 23, 2015 at 3:47 AM The Minimally Invasive Urology Institute (MIUI) at The Miriam Hospital is offering UroLift as one of the newest surgical treatments available for men with benign prostatic hyperplasia (BPH), an enlarged prostate condition. An enlarged prostate becomes more common with age. With BPH, the prostate gland surrounding the urethra enlarges […]Continue Reading ...
August 7, 2014 at 1:05 PM Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis Association (TMA), the only nonprofit organization dedicated to solely serving all patients with inflammatory myopathies, today announced a collaboration to advance a new potential treatment […]Continue Reading ...
January 16, 2017 at 4:38 AM Lung Cancer Navigator is a Customized Communication Hub that Puts Education, Care Management and Personal Support in the Palm of Your Hand LUNGevity, the nation’s leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably […]Continue Reading ...
- Piece of puzzle unlocked in what drives alcohol addiction
- Researchers investigate whether Zika reservoirs are found in the Americas
- Compounds found in coffee may inhibit growth of prostate cancer
- Lab Innovations returns to the NEC on 30 & 31 October 2019
- How genes affect tobacco and alcohol use
- Plant cellulose bone implants are “viable” option to support new bone growth, study finds
- Older people living in retirement communities benefit from improved health
- UTSA professor helps train first responders to detect prescription opioid overdoses
- Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
- Smoking may limit body’s ability to fight dangerous form of skin cancer
- Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
- TGen and ABL sign agreement to distribute new TB test technology
- UCD researchers lead development of new urine test to detect prostate cancer
- Miniature brains that can move muscles, grown in the lab
- Servier and Oncodesign announce research and drug development partnership
- FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
- TB Medicine Pretomanid Enters Regulatory Review Process in the United States
- Breastfeeding can erase effects of prenatal violence for newborns
- Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
- Space worries – shingles affecting astronauts says NASA